Usefulness of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients Under Maintenance Treatment With Anti-TNF Therapy: A Prospective Longitudinal Cohort Study

被引:0
|
作者
Ferreiro, Rocio
Barreiro-de Acosta, M.
Lorenzo-Gonzalez, Aurelio
Dominguez-Munoz, Enrique
机构
关键词
D O I
10.1016/S0016-5085(16)31459-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa1971
引用
下载
收藏
页码:S420 / S420
页数:1
相关论文
共 50 条
  • [1] Usefulness of consecutive faecal calprotectin measurements to predict relapse in inflammatory bowel disease patients under maintenance treatment with anti-TNF therapy: a prospective longitudinal cohort study
    Ferreiro, R.
    Barreiro-de Acosta, M.
    Lorenzo, A.
    Dominguez-Munoz, J. E.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S147 - S147
  • [2] Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients Under Maintenance With Anti-TNF Therapy A Prospective Longitudinal Cohort Study
    Ferreiro-Iglesias, Rocio
    Barreiro-de Acosta, Manuel
    Lorenzo-Gonzalez, Aurelio
    Dominguez-Munoz, Juan E.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2018, 52 (03) : 229 - 234
  • [3] Usefulness of monocytosis as biomarker to predict relapse in inflammatory bowel disease patients in remission under maintenance treatment with anti-TNF drugs: A prospective longitudinal cohort study
    Ferreiro, R.
    Lopez-Diaz, J.
    Baston, I.
    Dominguez-Munoz, J. E.
    Barreiro-de Acosta, M.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S213 - S214
  • [4] MONOCYTOSIS AS A BIOMARKER TO PREDICT RELAPSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE UNDER MAINTENANCE TREATMENT WITH ANTI-TNF DRUGS: A PROSPECTIVE, LONGITUDINAL COHORT STUDY
    Ferreiro, Rocio
    Lopez-Diaz, Javier
    Barreiro, Manuel
    Enrique Dominguez-Munoz, J.
    GASTROENTEROLOGY, 2017, 152 (05) : S394 - S394
  • [5] Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients
    Dai, Cong
    Cao, Qin
    Jiang, Min
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2019, 53 (04) : 314 - 314
  • [6] Reply to: Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients
    Ferreiro-Iglesias, Rocio
    Barreiro-de Acosta, Manuel
    Enrique Dominguez-Munoz, Juan
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2019, 53 (04) : 315 - 316
  • [7] Lipid profile in inflammatory bowel disease under maintenance wih anti-TNF: a prospective longitudinal cohort study
    Ferreiro, R.
    Lopez-Diaz, J.
    Lorenzo, A.
    Dominguez-Munoz, E.
    Barreiro-de Acosta, M.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S180 - S180
  • [8] Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance Infliximab Therapy
    Ferreiro-Iglesias, Rocio
    Barreiro-de Acosta, Manuel
    Otero Santiago, Manuel
    Lorenzo Gonzalez, Aurelio
    Alonso de la Pena, Carmen
    Benitez Estevez, Alfonso J.
    Enrique Dominguez-Munoz, Juan
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2016, 50 (02) : 147 - 151
  • [9] Fecal calprotectin in Inflammatory Bowel Disease treated with anti-TNF agents
    Marzo, M.
    Armuzzi, A.
    Felice, C.
    Forni, F.
    Papa, A.
    De Vitis, I
    Guidi, L.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (12) : S39 - S39
  • [10] Response to Anti-TNF Therapy in Hispanics With Inflammatory Bowel Disease: A Prospective Cohort Study
    Bonthala, Nirupama
    Demisse, Rahel
    Rezapour, Mona
    Hwang, Caroline
    GASTROENTEROLOGY, 2015, 148 (04) : S865 - S865